Intranasal Curcumin Inhibits Pulmonary Fibrosis by Modulating Matrix Metalloproteinase-9 (MMP-9) in Ovalbumin-Induced Chronic Asthma

Overview

Journal Inflammation

Specialties Allergy & Immunology
Pathology

Date 2016 Nov 21

PMID 27866296

Citations 22

Authors

Preeti S Chauhan

D Dash

Rashmi Singh

Affiliations

Soon will be listed here.

Abstract

Pulmonary fibrosis is associated with irreversible, or partially reversible, airflow obstruction and ultimately unresponsiveness to asthma therapies such as corticosteroids. Intranasal curcumin, an anti-inflammatory molecule, has been found effective in allergic asthma. To study the effect of intranasal curcumin on airway remodeling and fibrosis in murine model of chronic asthma, BALB/c mice were sensitized to ovalbumin (OVA) and exposed to OVA aerosol (2%) from day 21 (after sensitization) for 5 weeks (twice/week). Curcumin (intranasal) was administered during the OVA aerosol challenge. Mice exposed to OVA developed inflammation dominated by eosinophils which lead to fibrosis and airway remodeling. Intranasal administration of curcumin significantly inhibited airway inflammation and pulmonary fibrosis, where MMP-9 activities were decreased along with α-smooth muscle actin (α-SMA), MMP-9, TIMP-1, and eotaxin expressions. These results suggest that intranasal curcumin regulates airway inflammation and remodeling in chronic asthma.

Citing Articles

On the health effects of curcumin and its derivatives.

Ayub H, Islam M, Saeed M, Ahmad H, Al-Asmari F, Ramadan M Food Sci Nutr. 2024; 12(11):8623-8650.

PMID: 39620006 PMC: 11606848. DOI: 10.1002/fsn3.4469.

An Updated Comprehensive Review of Plants and Herbal Compounds with Antiasthmatic Effect.

Rajizadeh M, Najafipour H, Bejeshk M Evid Based Complement Alternat Med. 2024; 2024:5373117.

PMID: 39263346 PMC: 11390241. DOI: 10.1155/2024/5373117.

Green tea extract suppresses airway inflammation via oxidative stress-driven MAPKs/MMP-9 signaling in asthmatic mice and human airway epithelial cells.

Kim J, Kim J, Jeong J, Kim C, Chung E, Kim S Front Immunol. 2024; 15:1362404.

PMID: 38745671 PMC: 11091254. DOI: 10.3389/fimmu.2024.1362404.

Monomeric compounds from natural products for the treatment of pulmonary fibrosis: a review.

Li Z, Yang Y, Gao F Inflammopharmacology. 2024; 32(4):2203-2217.

PMID: 38724690 DOI: 10.1007/s10787-024-01485-0.

Progress in Understanding the Role and Therapeutic Targets of Polarized Subtypes of Macrophages in Pulmonary Fibrosis.

Sun Y, Xu H, Lu T, Li T, Wang Y, Fan X Cell Biochem Biophys. 2023; 81(4):673-682.

PMID: 37749443 DOI: 10.1007/s12013-023-01182-9.

References

Mautino G, Oliver N, Chanez P, Bousquet J, Capony F . Increased release of matrix metalloproteinase-9 in bronchoalveolar lavage fluid and by alveolar macrophages of asthmatics. Am J Respir Cell Mol Biol. 1997; 17(5):583-91. DOI: 10.1165/ajrcmb.17.5.2562. View

Cataldo D, Bettiol J, Noel A, Bartsch P, Foidart J, Louis R . Matrix metalloproteinase-9, but not tissue inhibitor of matrix metalloproteinase-1, increases in the sputum from allergic asthmatic patients after allergen challenge. Chest. 2002; 122(5):1553-9. DOI: 10.1378/chest.122.5.1553. View

Subhashini , Chauhan P, Kumari S, Kumar J, Chawla R, Dash D . Intranasal curcumin and its evaluation in murine model of asthma. Int Immunopharmacol. 2013; 17(3):733-43. DOI: 10.1016/j.intimp.2013.08.008. View

Ahmad T, Mabalirajan U, Hasija K, Ghosh B, Agrawal A . Mepacrine treatment attenuates allergic airway remodeling segregated from airway inflammation in mice. Int Immunopharmacol. 2010; 11(1):74-8. DOI: 10.1016/j.intimp.2010.10.008. View

Kuwano K, Bosken C, Pare P, Bai T, Wiggs B, Hogg J . Small airways dimensions in asthma and in chronic obstructive pulmonary disease. Am Rev Respir Dis. 1993; 148(5):1220-5. DOI: 10.1164/ajrccm/148.5.1220. View

Carroll N, Elliot J, Morton A, James A . The structure of large and small airways in nonfatal and fatal asthma. Am Rev Respir Dis. 1993; 147(2):405-10. DOI: 10.1164/ajrccm/147.2.405. View

Holgate S . Pathogenesis of asthma. Clin Exp Allergy. 2008; 38(6):872-97. DOI: 10.1111/j.1365-2222.2008.02971.x. View

Wenzel S, Balzar S, Cundall M, Chu H . Subepithelial basement membrane immunoreactivity for matrix metalloproteinase 9: association with asthma severity, neutrophilic inflammation, and wound repair. J Allergy Clin Immunol. 2003; 111(6):1345-52. DOI: 10.1067/mai.2003.1464. View

Kelly E, Busse W, Jarjour N . Increased matrix metalloproteinase-9 in the airway after allergen challenge. Am J Respir Crit Care Med. 2000; 162(3 Pt 1):1157-61. DOI: 10.1164/ajrccm.162.3.9908016. View

10.

Bloemen K, Verstraelen S, Van Den Heuvel R, Witters H, Nelissen I, Schoeters G . The allergic cascade: review of the most important molecules in the asthmatic lung. Immunol Lett. 2007; 113(1):6-18. DOI: 10.1016/j.imlet.2007.07.010. View

11.

Darby I, Laverdet B, Bonte F, Desmouliere A . Fibroblasts and myofibroblasts in wound healing. Clin Cosmet Investig Dermatol. 2014; 7:301-11. PMC: 4226391. DOI: 10.2147/CCID.S50046. View

12.

Maisi P, Prikk K, Sepper R, Pirila E, Salo T, Hietanen J . Soluble membrane-type 1 matrix metalloproteinase (MT1-MMP) and gelatinase A (MMP-2) in induced sputum and bronchoalveolar lavage fluid of human bronchial asthma and bronchiectasis. APMIS. 2003; 110(11):771-82. DOI: 10.1034/j.1600-0463.2002.1101102.x. View

13.

Hoshino M, Nakamura Y, Sim J, Shimojo J, Isogai S . Bronchial subepithelial fibrosis and expression of matrix metalloproteinase-9 in asthmatic airway inflammation. J Allergy Clin Immunol. 1998; 102(5):783-8. DOI: 10.1016/s0091-6749(98)70018-1. View

14.

Chauhan P, Subhashini , Dash D, Singh R . Intranasal curcumin attenuates airway remodeling in murine model of chronic asthma. Int Immunopharmacol. 2014; 21(1):63-75. DOI: 10.1016/j.intimp.2014.03.021. View

15.

Wynn T . Integrating mechanisms of pulmonary fibrosis. J Exp Med. 2011; 208(7):1339-50. PMC: 3136685. DOI: 10.1084/jem.20110551. View

16.

Johnson C, Galis Z . Matrix metalloproteinase-2 and -9 differentially regulate smooth muscle cell migration and cell-mediated collagen organization. Arterioscler Thromb Vasc Biol. 2003; 24(1):54-60. DOI: 10.1161/01.ATV.0000100402.69997.C3. View

17.

Todd N, Luzina I, Atamas S . Molecular and cellular mechanisms of pulmonary fibrosis. Fibrogenesis Tissue Repair. 2012; 5(1):11. PMC: 3443459. DOI: 10.1186/1755-1536-5-11. View

18.

Corry D, Rishi K, Kanellis J, Kiss A, Xu J, Feng L . Decreased allergic lung inflammatory cell egression and increased susceptibility to asphyxiation in MMP2-deficiency. Nat Immunol. 2002; 3(4):347-53. PMC: 2814346. DOI: 10.1038/ni773. View

19.

CHRISTENSEN P, Goodman R, Pastoriza L, Moore B, Toews G . Induction of lung fibrosis in the mouse by intratracheal instillation of fluorescein isothiocyanate is not T-cell-dependent. Am J Pathol. 1999; 155(5):1773-9. PMC: 1866962. DOI: 10.1016/S0002-9440(10)65493-4. View

20.

Huang J, Olivenstein R, Taha R, Hamid Q, Ludwig M . Enhanced proteoglycan deposition in the airway wall of atopic asthmatics. Am J Respir Crit Care Med. 1999; 160(2):725-9. DOI: 10.1164/ajrccm.160.2.9809040. View